Clinical Trials Details

A032001 (Urothelial)

MAIN-CAV: A Phase III Randomized Trial of Maintenance Carbozantinib and Avelumab vs. Maintenance Avelumab after First line platinum-based chemotherapy in Patients with Metastatic Urothelial Cancer

Objective

Key eligibility: Advanced or metastatic urothelial, of renal pelvis, ureter, bladder or urethra; no more than 1 line of prior chemo for mets.

» Learn more about this trial

Clinical Trial Categories

• Cancers and Other Neoplasms